<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Paul Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Rev Paul Pediatr</journal-id><journal-title-group><journal-title>Revista Paulista de Pediatria</journal-title></journal-title-group><issn pub-type="ppub">0103-0582</issn><issn pub-type="epub">1984-0462</issn><publisher><publisher-name>Sociedade de Pediatria de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24473958</article-id><article-id pub-id-type="pmc">4183044</article-id><article-id pub-id-type="publisher-id">S0103-05822013000400516</article-id><article-id pub-id-type="doi">10.1590/S0103-05822013000400015</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Lack of difference between continuous <italic>versus</italic>
intermittent heparin infusion on maintenance of intra-arterial catheter in
postoperative pediatric surgery: a randomized controlled study</article-title><trans-title-group xml:lang="es"><trans-title>Similitud entre infusi&#x000f3;n continua versus intermitente de soluci&#x000f3;n
de heparina en el mantenimiento de cat&#x000e9;ter intra-arterial en post-operatorio
de cirug&#x000ed;a pedi&#x000e1;trica: estudio randomizado controlado</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Witkowski</surname><given-names>Maria Carolina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>de Moraes</surname><given-names>Maria Antonieta P.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Firpo</surname><given-names>Cora Maria F.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Hospital de Cl&#x000ed;nicas de Porto Alegre, Porto Alegre, RS,
<country>Brasil</country></aff><aff id="aff2"><label>2</label>Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de Cardiologia, Porto Alegre, RS,
<country>Brasil</country></aff><author-notes><corresp id="c01"><bold>Endere&#x000e7;o para correspond&#x000ea;ncia: </bold>Maria Carolina Witkowski Avenida
Princesa Isabel, 370 - Santana CEP 90620-001 - Porto Alegre/RS E-mail:
<email>mariacarolinawit@hotmail.com</email></corresp><fn fn-type="conflict"><p>Conflito de interesse: nada a declarar</p></fn></author-notes><pub-date pub-type="epub-ppub"><month>12</month><year>2013</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>12</month><year>2013</year></pub-date><volume>31</volume><issue>4</issue><fpage>516</fpage><lpage>522</lpage><history><date date-type="received"><day>04</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>5</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License, which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>OBJECTIVE:</title><p> To compare two systems of arterial catheters maintenance in postoperative
pediatric surgery using intermittent or continuous infusion of heparin
solution and to analyze adverse events related to the site of catheter
insertion and the volume of infused heparin solution. </p></sec><sec><title>METHODS:</title><p> Randomized control trial with 140 patients selected for continuous infusion
group (CIG) and intermittent infusion group (IIG). The variables analyzed
were: type of heart disease, permanence time and size of the catheter,
insertion site, technique used, volume of heparin solution and adverse
events. The descriptive variables were analyzed by Student's
<italic>t</italic>-test and the categorical variables, by chi-square
test, being significant <italic>p</italic>&#x0003c;0.05. </p></sec><sec><title>RESULTS:</title><p> The median age was 11 (0-22) months, and 77 (55%) were females. No
significant differences between studied variables were found, except for the
volume used in CIG (12.0&#x000b1;1.2mL/24 hours) when compared to IIG (5.3&#x000b1;3.5mL/24
hours) with <italic>p</italic>&#x0003c;0.0003. </p></sec><sec><title>CONCLUSIONS:</title><p> The continuous infusion system and the intermittent infusion of heparin
solution can be used for intra-arterial catheters maintenance in
postoperative pediatric surgery, regardless of patient's clinical and
demographic characteristics. Adverse events up to the third postoperative
day occurred similarly in both groups. However, the intermittent infusion
system usage in underweight children should be considered, due to the lower
volume of infused heparin solution [ClinicalTrials.gov Identifier:
NCT01097031].</p></sec></abstract><trans-abstract xml:lang="es"><sec><title>OBJETIVOS:</title><p> Comparar dos sistemas de mantenimiento de cat&#x000e9;teres arteriales en
post-operatorio de cirug&#x000ed;a card&#x000ed;aca pedi&#x000e1;trica, utilizando infusi&#x000f3;n continua
o intermitente de soluci&#x000f3;n de heparina, y analizar los eventos adversos
relacionados al local de inserci&#x000f3;n del cat&#x000e9;ter y el volumen de soluci&#x000f3;n de
heparina infundido. </p></sec><sec><title>M&#x000c9;TODOS:</title><p> Ensayo cl&#x000ed;nico randomizado controlado, con 140 pacientes seleccionados para
el Grupo Infusi&#x000f3;n Continua (GIC) y el Grupo Infusi&#x000f3;n Intermitente (GII). Las
variables analizadas fueron: tipo de cardiopat&#x000ed;a, tiempo de permanencia y
tama&#x000f1;o del cat&#x000e9;ter, local de inserci&#x000f3;n, t&#x000e9;cnica empleada, volumen de
soluci&#x000f3;n de heparina y eventos adversos. Se utiliz&#x000f3; la prueba
<italic>t</italic> de Student para variables descriptivas y la prueba
del chi-cuadrado para variables categ&#x000f3;ricas, siendo significante
<italic>p</italic>&#x0003c;0,05. </p></sec><sec><title>RESULTADOS:</title><p> La mediana de edad fue de 11 (0-22,1) meses, siendo 77 (55%) del sexo
femenino. No hubo diferencia significativa en las variables analizadas,
excepto por el volumen infundido en el GIC (12,0&#x000b1;1,2mL/24 horas), cuando
comparado al del GII (5,3&#x000b1;3,5mL/24 horas), con <italic>p</italic>&#x0003c;0,0003.
</p></sec><sec><title>CONCLUSIONES:</title><p> Tanto el sistema de infusi&#x000f3;n continua cuanto el sistema intermitente de
soluci&#x000f3;n de heparina pueden ser utilizados en el mantenimiento de cat&#x000e9;ter
intra-arterial en post-operatorio de cirug&#x000ed;a pedi&#x000e1;trica, independiente de
las caracter&#x000ed;sticas cl&#x000ed;nicas y demogr&#x000e1;ficas de los pacientes, as&#x000ed; como de la
ocurrencia de eventos adversos hasta el tercer d&#x000ed;a del post-quir&#x000fa;rgico. Sin
embargo, se debe considerar la utilizaci&#x000f3;n del sistema de infusi&#x000f3;n
intermitente en ni&#x000f1;os de bajo peso, debido al menor volumen de soluci&#x000f3;n de
heparina infundido (registro en el <italic>Clinical Trials</italic> bajo el
n&#x000ba; NCT01097031).</p></sec></trans-abstract><kwd-group><kwd>postoperative care</kwd><kwd>pediatrics</kwd><kwd>catheterization, peripheral</kwd></kwd-group><counts><fig-count count="2"/><table-count count="2"/><ref-count count="29"/><page-count count="7"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The process of post-operative cardiac surgery depends on several factors, from the
type of heart disease and the weight of the patient to the hospital structure,
including a team of specialized health and appropriate equipment. In the clinical
context of the child in the postoperative period, the monitoring of invasive blood
pressure is an important parameter to consider in order to detect rapid oscillations
of pressure and obtain samples for laboratory tests<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. However, the approach in dealing with the patency and maintenance of
arterial catheters routinely used in pediatric intensive care is not fully
established. Studies show that, although the use of arterial catheters is essential
for patient care, the occurrence of adverse events that should be detected and
treated early is frequent<sup>(</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>-</sup>
<xref rid="B14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup>.</p><p>A systematic review and meta-analysis evaluated the effect of heparin, length of
stay, and complications of arterial and venous catheters in children and adults
admitted to intensive care. The findings indicate that the intermittent use of
heparin solution in concentrations of 10UI/mL was beneficial, compared to the
isolated use of 0.9% saline solution. With this concentration of heparin solution,
catheters remained permeable for a longer time compared to the group receiving
saline solution at 0.9%<sup>(</sup>
<xref rid="B15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup>.</p><p>Recent study included review of clinical trials comparing different methods of
maintaining patency of central venous catheters in adults. The authors concluded
that there is not enough evidence to suggest the best technique to be employed and
claimed that new studies are needed<sup>(</sup>
<xref rid="B16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>,</sup>
<xref rid="B17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup>.</p><p>Due to the lack of evidence regarding the most suitable technique for the maintenance
of arterial catheters in children by means of an infusion of heparin solution system
or intermittent infusion of heparin solution, safe strategies are needed to secure
the highest care for this population in greater risk. Thus, the objectives of this
study were to compare two systems of arterial catheters maintenance in postoperative
pediatric cardiac surgery using continuous or intermittent infusion of heparin
solution, and to describe the clinical and demographic characteristics of children
and analyze adverse events related to the site of catheter insertion and the volume
of heparin solution infused.</p></sec><sec sec-type="methods"><title>Method</title><p>Randomized controlled trial comparing two systems of maintenance and patency of
arterial catheters in patients consecutively admitted in the Intensive Care Unit of
a Cardiology Hospital from October 2007 to April 2009.</p><p>Randomization was performed by random drawing with sealed envelopes containing the
group in which the patient would be included: Continuous Infusion Group (CIG) or
Intermittent Infusion Group (IIG). The study was registered in Clinical Trials under
No. NTC01097031. The nursing staff of the unit prepared and administered the heparin
solution, according to the established routine: vials of intravenous heparin
5.000UI/mL diluted with saline solution at 0.9% in 250mL bottles, yielding a final
concentration of 4IU/mL. After the final dilution stability of the solutions had 24
hours, and replaced as they had completed this period.</p><p>Children of both sexes were included, weighing &#x0003c;15kg, submitted to cardiac surgery
and admitted to the Pediatric Intensive Care Unit. Other pediatric surgeries and
weight above 15kg were considered exclusion criteria.</p><p>In IIG, patients were randomly selected for maintenance and patency of arterial
catheters for intermittent infusion of heparin. BD<sup>(r)</sup> syringes with 5 ml
heparin solution with a concentration of 4IU/mL (heparin/saline solution 0.9%) were
used. The system was connected to the patient and to the pressure transducer via
BD<sup>(r)</sup> extenders; the pressure transducer, in turn, was connected to
the monitor to display the continuous curve of blood pressure. Infusions were made
only when needed: in cases of blood reflux for system calibration and laboratory
exams.</p><p>In CIG, patients were randomly selected to maintain and permeabilize arterial
catheters by continuous infusion with a Nikiso<sup>(r)</sup> infusion pump syringe
at a rate of 0.5mL/h, with a solution of heparin at a concentration of 4IU/mL
(heparin/saline solution at 0.9%). The system was connected to the patient and the
pressure transducer, using the infusion pump in a total of 12mL of a solution of
heparin per 24 hours. When needed, to perform laboratory samples, flushes of heparin
solution were conducted manually by an infusion pump with appropriate volume to fill
with extents solution of heparin and a good view on the monitor pressure curve.</p><p>For data collection, we elaborated an instrument in which the demographic and
clinical variables were recorded to characterize the sample, such as age, weight,
sex, type of heart disease, surgery, catheter insertion site, volume of heparin
solution, and time of catheter permanence. Adverse effects such as bleeding
(presence of blood in the dressing or at the site of puncture of the catheterized
artery); edema (abnormal accumulation of fluid in the local interstitial site and
observed by increased circumference of the catheterized limb over the opposite
limb); hematoma (accumulation of blood in the subcutaneous tissue at the puncture
site and noticed on palpation), poor perfusion (inappropriate initial stage of
capillary refill); ischemia (more advanced stage of perfusion in which there is
damaged tissue); presence of blood clots (absence of blood reflux into the catheter
and presence of thrombus within it after removal)<sup>(</sup>
<xref rid="B18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>)</sup>.</p><p>The health care team of the unit under study (doctors and nurses) registered all
variables and one of the authors collected data in four distinct stages: immediate
postoperative period (IPO) - from the patient's arrival in the Pediatric Intensive
Care Unit up to 24 hours; first postoperative day (1st PO) - after 24 hours up to 48
hours after surgery; second day after surgery (2nd PO) - after 48 hours up to
complete 72 hours; third postoperative day (3rd PO) - 72 hours after surgery.</p><p>The study was developed in accordance with the Guidelines and Standards for Research
Involving Humans, and was approved by the Research Ethics Committee of the Institute
of Cardiology of Rio Grande do Sul/Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de Cardiologia).
Parents/guardians were invited to participate and signed the informed consent
form.</p><p>Data were analyzed with the Statistical Package for Social Sciences (SPSS) 14.0.
Categorical variables were described by absolute and relative frequencies, and
continuous variables as mean and standard deviation, or median and interquartile
range (25th and 75th percentiles) according to whether they follow normal
distribution or not. We used Person's chi-square test to compare categorical
variables. Student's <italic>t</italic> test was used to compare the means and
medians between groups, according to whether the parametric assumptions were
respected or not. Significance was established at <italic>p</italic>&#x0003c;0.05.</p><p>For a sample of 70 subjects in each group, there was a standard deviation of 15.5 and
14.8, to detect a difference greater than 8 days of catheter permanence, power of
87% was obtained.</p></sec><sec sec-type="results"><title>Results</title><p>We selected 141 children in postoperative of cardiac surgery, and one did not
participate in the study due to lack of consent from parents/guardians (<xref ref-type="fig" rid="f01">Figure 1</xref>). Thus, 140 patients were included,
being 77 (55%) female. The median age was 11 months (from 0 to 22.1 months) and the
median weight was 7.4kg (1.9-14.9kg).</p><p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title> Flowchart of patients included in the study</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gf01"/></fig>
</p><p>As for the most common congenital heart defects, 26 (18.6%) children were diagnosed
with tetralogy of Fallot, 14 (10%) with ventricular septal defect (VSD) and 13
(9.3%) with pulmonary atresia with VSD for both groups analyzed (<xref ref-type="table" rid="t01">Table 1</xref>).</p><p>
<table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title> Clinical and demographic characteristics of the population
(n=140)</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gt01"/></table-wrap>
</p><p>Regarding adverse events during the 3 first postoperative days, there was bleeding,
edema, hematoma, poor perfusion, ischemia, or blood clot in 63 (45%) children, with
no significant difference when comparing the two groups (<italic>p</italic>=0.82)
(<xref ref-type="table" rid="t02">Table 2</xref>).</p><p>
<table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title> Adverse effects related to site of catheter insertion</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gt02"/></table-wrap>
</p><p>Still considering the two groups, in 28 (20%) cases there was no breach of catheters
and 27 (19.3%) children were discharged from the intensive care unit until the 3rd
day after surgery, reasons that led to the removal of catheters.</p><p>When evaluating the insertion site of the catheter, in 56 (40%) children the left
radial artery was used, and in 40 (28.6%) children, the right radial artery, for
both groups. Puncture through transfixation of the artery was used in 138 (97.9%)
children, and only in one (1.4%) child for each group, dissection was used. The
caliber of the most used catheter was 24G in 78 (55.7%) children.</p><p>Regarding the time of permanence of the catheters, the median was 48 (24 to 70.5)
hours in CIG and 48 (32 to 76.5) hours in IIG. As no difference greater than 8 days
of catheter permanence was found, there was no difference between groups
(<italic>p</italic>=1.0). Comparing the average volume used in the IIG
(5.3&#x000b1;3.5mL/24 hours) with the CIG (12.0&#x000b1;1.2mL/24 hours), the findings showed a
significant difference (<italic>p</italic>&#x0003c;0.0003) (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p><p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title> Volume of heparin solution used very 24 hours in both groups</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gf02"/></fig>
</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The invasive blood pressure monitoring in children has been widely used in various
services of Pediatrics. Currently, arterial catheterization is a procedure indicated
whenever a child is undergoing heart surgery. Because is it easily achievable,
especially when punctured, it allows obtaining fast and accurate blood pressure and
thus also provides the collection of blood samples for laboratory tests<sup>(</sup>
<xref rid="B19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>)</sup>. The success of invasive measurement of blood pressure only occurs when
the system maintaining catheter patency does not compromise patient safety or the
accuracy and reproducibility of the measurement.</p><p>The present study compared two systems of maintenance and permeabilization of
arterial catheters in children. The main result demonstrated was related to the
volume of heparin solution used in both groups. The mean volume used in the IIG was
lower when compared to the CIG.</p><p>The continuous infusion system is a comfortable method for the handler and provides a
larger safety margin regarding the volume infused, compared to the technique of
rapid flushes. The method of intermittent infusion provides better observation of
the entire system as to the presence of air and blood clotting through reflux of
blood by negative pressure via syringe. According to a study conducted in children,
systems of continuous infusion decreased the incidence of distal embolization from
23 to 0% and also provide a better control of the amount of infusion of
heparin<sup>(</sup>
<xref rid="B20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>.</p><p>The occurrence of a greater number of complications is related to the patients that
present shock or low output<sup>(</sup>
<xref rid="B21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. It is possible that the large number of clots noticed in the present
study was associated to the severity of patients. Because they are cardiopaths, many
submitted to cardiac surgery with cardiopulmonary bypass, they often presented heart
failure and low-output state.</p><p>Usually, children under 5 years old have a higher rate of complications of arterial
catheterization, requiring greater care in monitoring invasive blood pressure due to
rapid changes which are subjected to hemodynamic instability and the use of
vasoactive drugs in the postoperative<sup>(</sup>
<xref rid="B11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>)</sup>. In this study, there were no significant differences regarding age and
weight of children related to adverse events. In another observational,
retrospective study, conducted with 1,473 children up to 20kg, there was often
temporary occlusion of the cannulated artery<sup> (8)</sup>. The puncture site
usually chosen and with greater ease of access was radial and brachial, followed by
femoral, coincident with data obtained in this study.</p><p>There was great variability in the time of patency of the catheters with a median of
48 hours in both groups. Some studies showed higher mean of time of permanence, with
an average duration of 72 hours for arterial catheters<sup>(</sup>
<xref rid="B22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>. Other observed mean permanece time of 48 hours<sup>(</sup>
<xref rid="B22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>,</sup>
<xref rid="B23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>. Authors reported that the use of the arterial catheter should not
exceed 96 hours to reduce the risk of infection<sup>(</sup>
<xref rid="B24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. In this study, the great variability of time related to the duration
of the arterial catheter is probably due to the great variability in length of stay
in the Intensive Care Unit. Many of these patients had serious postoperative
complications, requiring prolonged mechanical ventilation, peritoneal dialysis, and
continuous monitoring to record blood pressure and to obtain samples for laboratory
specimens.</p><p>Comparing the average volume used in the IIG (5.3&#x000b1;3.5 mL/24 hours) with the mean of
CIG (12&#x000b1;1.2mL/24 hours), there was a significant difference in the daily values of
heparin solution infused in each group. It is questionable whether this difference,
which is statistically significant, has some impact on clinical practice. On the
other hand, the control of blood volume in pediatric patients is one of the primary
precautions for the good hemodynamic evolution. In very young children, the
necessary volume to infuse drugs may contribute to volume overload<sup>(</sup>
<xref rid="B25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>,</sup>
<xref rid="B26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>.</p><p>The dose of heparin used in the literature ranges from 0.1-10UI/mL<sup>(</sup>
<xref rid="B27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup>. In this study, we used concentrations of heparin solution at 4UI/mL in
both groups. The findings showed that 45% of patients had some adverse event. Among
these, 25% showed the presence of blood clot, a relatively high rate when compared
to other studies. Some authors demonstrated a low complication rate, with only 3% of
catheter occlusion when using a heparin solution continuously, at 3mL/h<sup>(</sup>
<xref rid="B26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>. A study performed with adult patients reported no difference in
patency of the catheters when comparing maintenance with normal saline at 0.9% and
saline solution at 0.9% with heparin, but found differences in the accuracy of the
values of blood pressure measurement, and the most accurate values were observed in
the group using heparin<sup>(</sup>
<xref rid="B28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>. In children from 1 month to 2 years old catheterized in the radial
artery and connected to a device with a continuous infusion, at 3mL/h with
heparinized isotonic saline at 1IU heparin / mL, there was a higher number of
haemorrhage and ischemia in the first 72 hours<sup>(</sup>
<xref rid="B29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p><p>Volume overload and renal failure are factors that contribute significantly to
increased postoperative morbidity and mortality, especially in newborns. Fluid
restriction is a resource that is used frequently, often to the tolerated extent. In
such circumstances any volume infused can be significant<sup>(</sup>
<xref rid="B29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p><p>It can be concluded that the choice of the system of continuous or intermittent
infusion of a solution of heparin to maintain intra-arterial catheter, is
independent of the clinical and demographic characteristics of the infants or the
occurrence of adverse events during the first 3 days of postoperative, as evidenced
in the sample. However, the use of the intermittent infusion in children of low
birth weight should be considered, due to a lower volume of heparin solution
infused.</p><p>Characteristics such as caliber of catheters, choice of insertion site, and technique
used for insertion showed no evidence of increased length of stay in both groups. A
limitation of the study lies in the fact that the number of times the catheter was
manipulated by different professionals was not registered. The greater manipulation
of catheters through the rapid flushes technique may have occurred in the system of
intermittent infusion, which could influence the effectiveness of this system.
Therefore, further studies are needed on the topic.</p></sec></body><back><fn-group><fn fn-type="other"><p>Institui&#x000e7;&#x000e3;o: Instituto de Cardiologia do Rio Grande do Sul/Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria
de Cardiologia, Porto Alegre, RS, Brasil</p></fn></fn-group><ref-list><title>References</title><ref id="B01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyague</surname><given-names>NI</given-names></name><name><surname>Cardoso</surname><given-names>SM</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Ultramari</surname><given-names>FT</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>FH</given-names></name><name><surname>Rozkowisk</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="pt">Estudo epidemiol&#x000f3;gico de cardiopatias cong&#x000ea;nitas na
inf&#x000e2;ncia e adolesc&#x000ea;ncia. An&#x000e1;lise em 4.538 casos</article-title><source>Arq Bras Cardiol</source><year>2003</year><volume>80</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">12856270</pub-id></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>[homepage on the Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>causes of death in neonates and children under five in the
world: the global burden of disease </publisher-name><date-in-citation content-type="access-date" iso-8601-date="2009-06-10">cited
2009 Jun 10</date-in-citation><comment>a Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/child_adolescent_health/media/causes_death_u5_neonates_2004.pdf">Available from:
http://www.who.int/child_adolescent_health/media/causes_death_u5_neonates_2004.pdf</ext-link></comment><year>2009</year></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auler</surname><given-names>JO</given-names><suffix>Jr</suffix></name><name><surname>Barreto</surname><given-names>AC</given-names></name><name><surname>Gimenez</surname><given-names>SC</given-names></name><name><surname>Abellan</surname><given-names>DM</given-names></name></person-group><article-title>Pediatric cardiac postoperative
care</article-title><source>Rev Hosp Clin Fac Med Sao Paulo</source><year>2002</year><volume>57</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">12118270</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>D</given-names></name><name><surname>Silva</surname><given-names>KV</given-names></name><name><surname>Novello</surname><given-names>R</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>TC</given-names></name><name><surname>Silva</surname><given-names>VG</given-names></name></person-group><article-title>Nursing assistance in child with heart
disease</article-title><source>Rev SOCERJ</source><year>2000</year><volume>13</volume><fpage>22</fpage><lpage>29</lpage></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albisetti</surname><given-names>M</given-names></name><name><surname>Schmugge</surname><given-names>M</given-names></name><name><surname>Haas</surname><given-names>R</given-names></name><name><surname>Eckhardt</surname><given-names>BP</given-names></name><name><surname>Bauersfeld</surname><given-names>U</given-names></name><name><surname>Baenziger</surname><given-names>O</given-names></name><etal/></person-group><article-title>Arterial thromboembolic complications in critically
ill children</article-title><source>J Crit Care</source><year>2005</year><volume>20</volume><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">16253802</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>[homepage on the Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>The global burden of disease: causes of death in neonates and
children under five in the region of the Americas</publisher-name><date-in-citation content-type="access-date" iso-8601-date="2009-06-10">cited
2009 Jun 10</date-in-citation><comment>a Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/">Available from:
http://www.who.int/</ext-link></comment><year>2009</year></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atik</surname><given-names>FA</given-names></name></person-group><article-title xml:lang="pt">Monitoriza&#x000e7;&#x000e3;o hemodin&#x000e2;mica em cirurgia card&#x000ed;aca
pedi&#x000e1;trica</article-title><source>Arq Bras Cardiol</source><year>2004</year><volume>82</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">15042259</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindler</surname><given-names>E</given-names></name><name><surname>Kowald</surname><given-names>B</given-names></name><name><surname>Suess</surname><given-names>H</given-names></name><name><surname>Niehaus-Borquez</surname><given-names>B</given-names></name><name><surname>Tausch</surname><given-names>B</given-names></name><name><surname>Brecher</surname><given-names>A</given-names></name></person-group><article-title>Catheterization of the radial or brachial artery in
neonates and infants</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>677</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">16029403</pub-id></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>VL</given-names></name><name><surname>Kruse</surname><given-names>JA</given-names></name></person-group><article-title>Arterial catheterization</article-title><source>Crit Care Clin</source><year>1992</year><volume>8</volume><fpage>687</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">1327430</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>LP</given-names></name><name><surname>Rivero</surname><given-names>MP</given-names></name><name><surname>Sigler</surname><given-names>OM</given-names></name><name><surname>Morej&#x000f3;n</surname><given-names>AG</given-names></name></person-group><article-title xml:lang="pt">Cateterizaci&#x000f3;n de la arteria radial</article-title><source>Rev Cub Cir</source><year>1988</year><volume>27</volume><fpage>28</fpage><lpage>31</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith-Wright</surname><given-names>DL</given-names></name><name><surname>Green</surname><given-names>TP</given-names></name><name><surname>Lock</surname><given-names>JE</given-names></name><name><surname>Egar</surname><given-names>MI</given-names></name><name><surname>Fuhrman</surname><given-names>BP</given-names></name></person-group><article-title>Complications of vascular catheterization in
critically ill children</article-title><source>Crit Care Med</source><year>1984</year><volume>12</volume><fpage>1015</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">6509996</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adar</surname><given-names>R</given-names></name><name><surname>Rubinstein</surname><given-names>N</given-names></name><name><surname>Blieden</surname><given-names>L</given-names></name></person-group><article-title>Immediate complications and late sequelae of
arterial catheterization in children with congenital heart
disease</article-title><source>Pediatr Cardiol</source><year>1983</year><volume>4</volume><fpage>25</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">6844149</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furfaro</surname><given-names>S</given-names></name><name><surname>Gauthier</surname><given-names>M</given-names></name><name><surname>Lacroix</surname><given-names>J</given-names></name><name><surname>Nadeau</surname><given-names>D</given-names></name><name><surname>Lafleur</surname><given-names>L</given-names></name><name><surname>Mathews</surname><given-names>S</given-names></name></person-group><article-title>Arterial catheter-related infections in children. A
1-year cohort analysis</article-title><source>Am J Dis Children</source><year>1991</year><volume>145</volume><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">1877564</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>PS</given-names></name><name><surname>Shah</surname><given-names>VS</given-names></name></person-group><article-title>Continuous heparin infusion to prevent thrombosis
and catheter occlusion in neonates with peripherally placed percutaneous
central venous catheters</article-title><source>Cochrane Database Syst Rev [serial on the Internet]</source><year>2008</year><issue>2</issue><fpage>CD002772 </fpage><lpage>CD002772 </lpage><date-in-citation content-type="access-date" iso-8601-date="2013-06-17">2013 Jun
17</date-in-citation><comment>a Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18425882">Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18425882</ext-link></comment></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>AG</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Gonzales</surname><given-names>CA</given-names></name><name><surname>Andrew</surname><given-names>M</given-names></name></person-group><article-title>Benefit of heparin in peripheral venous and
arterial catheters: systematic review and meta-analysis of randomised
controlled trials</article-title><source>BMJ</source><year>1998</year><volume>316</volume><fpage>969</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">9550955</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>MD</given-names></name><name><surname>Anderson</surname><given-names>BJ</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Umscheid</surname><given-names>CA</given-names></name></person-group><article-title>Heparin flushing and other interventions to
maintain patency of central venous catheters: a systematic
review</article-title><source>J Adv Nurs</source><year>2009</year><volume>65</volume><fpage>2007</fpage><lpage>2021</lpage><pub-id pub-id-type="pmid">20568318</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maya</surname><given-names>LC</given-names></name><name><surname>Restrepo</surname><given-names>NH</given-names></name></person-group><article-title xml:lang="es">Cateterismo arterial en pacientes pedi&#x000e1;tricos.
Experiencia con 100 l&#x000ed;neas arteriales</article-title><source>Pediatr&#x000ed;a (Bogot&#x000e1;)</source><year>1994</year><volume>29</volume><fpage>97</fpage><lpage>101</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guyton</surname><given-names>AC</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name></person-group><source>Textbook of medical physiology</source><edition>11</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier Saunder</publisher-name><year>2006</year></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalonen</surname><given-names>J</given-names></name></person-group><article-title>Invasive haemodynamic monitoring: concepts and
practical approaches</article-title><source>Ann Med</source><year>1997</year><volume>29</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">9375989</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzo</surname><given-names>RB</given-names></name></person-group><article-title xml:lang="es">Monitoreo invasivo de la presi&#x000f3;n arterial en el
ni&#x000f1;o</article-title><source>Pediatr&#x000ed;a (Santiago de Chile)</source><year>1991</year><volume>34</volume><fpage>22</fpage><lpage>31</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Neff</surname><given-names>M</given-names></name><name><surname>Heijboer</surname><given-names>H</given-names></name><name><surname>van Woensel</surname><given-names>JB</given-names></name><name><surname>de Haan</surname><given-names>RJ</given-names></name></person-group><article-title>The efficacy of heparinization in prolonging
patency of arterial and central venous catheters in children: a randomized
double-blind trial</article-title><source>Pediatr Hematol Oncol</source><year>2002</year><volume>18</volume><fpage>553</fpage><lpage>560</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saladino</surname><given-names>R</given-names></name><name><surname>Bachman</surname><given-names>D</given-names></name><name><surname>Fleisher</surname><given-names>G</given-names></name></person-group><article-title>Arterial access in the pediatric emergency
department</article-title><source>Ann Emerg Med</source><year>1990</year><volume>19</volume><fpage>382</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">2321823</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>E</given-names></name><name><surname>Freiberg</surname><given-names>A</given-names></name><name><surname>Salter</surname><given-names>DR</given-names></name></person-group><article-title>Radial artery infections and aneurysms after
catheterization</article-title><source>J Hand Surg Am</source><year>1990</year><volume>15</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">2299159</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>M</given-names></name><name><surname>Elsner</surname><given-names>C</given-names></name><name><surname>Ouellet</surname><given-names>D</given-names></name><name><surname>Zeldin</surname><given-names>R</given-names></name></person-group><article-title>Heparinized saline versus normal saline in
maintaining patency of the radial artery catheter</article-title><source>Can J Surg</source><year>1994</year><volume>37</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">8306218</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Deorari</surname><given-names>AK</given-names></name><name><surname>Paul</surname><given-names>VK</given-names></name><name><surname>Bagga</surname><given-names>A</given-names></name></person-group><article-title>Acute renal failure in neonates</article-title><source>Indian J Pediatr</source><year>2008</year><volume>75</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">18536895</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>JM</given-names></name><name><surname>Douglas</surname><given-names>D</given-names></name></person-group><article-title>Fluid and electrolyte management in the premature
infant</article-title><source>Neonatal Netw</source><year>2008</year><volume>27</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">19065967</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>PS</given-names></name><name><surname>Ng</surname><given-names>E</given-names></name><name><surname>Sinha</surname><given-names>AK</given-names></name></person-group><article-title>Heparin for prolonging peripheral intravenous
catheter use in neonates.</article-title><source>Cochrane Database Syst Rev [serial on the Internet]</source><year>2002</year><issue>4</issue><fpage>CD002774</fpage><lpage>CD002774</lpage><date-in-citation content-type="access-date" iso-8601-date="2012-08-18">cited
2012 Aug 18</date-in-citation><comment>a Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12519576">Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12519576</ext-link></comment></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>N</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><name><surname>Carvalho</surname><given-names>WB</given-names></name><name><surname>Souza</surname><given-names>RL</given-names></name><name><surname>Oliveira</surname><given-names>NF</given-names></name></person-group><article-title xml:lang="pt">Complica&#x000e7;&#x000f5;es da cateteriza&#x000e7;&#x000e3;o arterial em
crian&#x000e7;as</article-title><source>Rev Assoc Med Bras</source><year>2000</year><volume>46</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10770901</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duke</surname><given-names>T</given-names></name><name><surname>Molyneux</surname><given-names>EM</given-names></name></person-group><article-title>Intravenous fluids for seriously ill children: time
to reconsider</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1320</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">14575980</pub-id></element-citation></ref></ref-list></back><sub-article id="S01" article-type="translation" xml:lang="pt"><front-stub><article-categories><subj-group subj-group-type="heading"><subject>Artigos Originais</subject></subj-group></article-categories><title-group><article-title>Similaridade entre infus&#x000e3;o cont&#x000ed;nua versus intermitente de solu&#x000e7;&#x000e3;o de
heparina na manuten&#x000e7;&#x000e3;o de cateter intra-arterial em p&#x000f3;s-operat&#x000f3;rio de cirurgia
pedi&#x000e1;trica: estudo randomizado controlado</article-title></title-group><abstract><sec><title>OBJETIVOS:</title><p> Comparar dois sistemas de manuten&#x000e7;&#x000e3;o de cateteres arteriais em
p&#x000f3;s-operat&#x000f3;rio de cirurgia card&#x000ed;aca pedi&#x000e1;trica, utilizando infus&#x000e3;o cont&#x000ed;nua
ou intermitente de solu&#x000e7;&#x000e3;o de heparina, e analisar os eventos adversos
relacionados ao local de inser&#x000e7;&#x000e3;o do cateter e o volume de solu&#x000e7;&#x000e3;o de
heparina infundido. </p></sec><sec><title>M&#x000c9;TODOS:</title><p> Ensaio cl&#x000ed;nico randomizado controlado, com 140 pacientes selecionados para o
Grupo Infus&#x000e3;o Cont&#x000ed;nua (GIC) e o Grupo Infus&#x000e3;o Intermitente (GII). As
vari&#x000e1;veis analisadas foram: tipo de cardiopatia, tempo de perman&#x000ea;ncia e
tamanho do cateter, local de inser&#x000e7;&#x000e3;o, t&#x000e9;cnica empregada, volume de solu&#x000e7;&#x000e3;o
de heparina e eventos adversos. Utilizou-se o teste <italic>t</italic> de
Student para vari&#x000e1;veis descritivas e o teste do qui-quadrado para vari&#x000e1;veis
categ&#x000f3;ricas, sendo significante <italic>p</italic>&#x0003c;0,05. </p></sec><sec><title>RESULTADOS:</title><p> A mediana de idade foi de 11 (0-22) meses, sendo 77 (55%) do sexo feminino.
N&#x000e3;o houve diferen&#x000e7;a significativa nas vari&#x000e1;veis analisadas, com exce&#x000e7;&#x000e3;o do
volume infundido no GIC (12,0&#x000b1;1,2mL/24 horas), quando comparado ao do GII
(5,3&#x000b1;3,5mL/24 horas), com <italic>p</italic>&#x0003c;0,0003. </p></sec><sec><title>CONCLUS&#x000d5;ES:</title><p> Tanto o sistema de infus&#x000e3;o cont&#x000ed;nua quanto o sistema intermitente de solu&#x000e7;&#x000e3;o
de heparina podem ser utilizados na manuten&#x000e7;&#x000e3;o de cateter intra-arterial em
p&#x000f3;s-operat&#x000f3;rio de cirurgia pedi&#x000e1;trica, independentemente das caracter&#x000ed;sticas
cl&#x000ed;nicas e demogr&#x000e1;ficas dos pacientes, bem como da ocorr&#x000ea;ncia de eventos
adversos at&#x000e9; o terceiro dia p&#x000f3;s-cir&#x000fa;rgico. Entretanto, deve-se considerar a
utiliza&#x000e7;&#x000e3;o do sistema de infus&#x000e3;o intermitente em crian&#x000e7;as de baixo peso,
devido ao menor volume de solu&#x000e7;&#x000e3;o de heparina infundido [registro no
<italic>Clinical Trials</italic> sob o n&#x000ba; NCT01097031].</p></sec></abstract><kwd-group xml:lang="pt"><kwd>cuidados p&#x000f3;s-operat&#x000f3;rios</kwd><kwd>pediatria</kwd><kwd>cateterismo perif&#x000e9;rico</kwd></kwd-group></front-stub><body><sec><title>Introdu&#x000e7;&#x000e3;o</title><p>O processo de recupera&#x000e7;&#x000e3;o p&#x000f3;s-operat&#x000f3;ria da cirurgia card&#x000ed;aca pedi&#x000e1;trica depende
de v&#x000e1;rios fatores, desde o tipo de cardiopatia e o peso do paciente at&#x000e9; a
estrutura hospitalar, incluindo uma equipe de sa&#x000fa;de especializada e equipamentos
adequados. No contexto cl&#x000ed;nico da crian&#x000e7;a em p&#x000f3;s-operat&#x000f3;rio de cirurgia
card&#x000ed;aca, a monitoriza&#x000e7;&#x000e3;o da press&#x000e3;o arterial de forma invasiva &#x000e9; um importante
par&#x000e2;metro a se considerar, para que se detectem oscila&#x000e7;&#x000f5;es r&#x000e1;pidas de press&#x000e3;o e
se obtenham coletas para exames laboratoriais<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. No entanto, a abordagem para lidar com a permeabilidade e a
manuten&#x000e7;&#x000e3;o desses cateteres arteriais, rotineiramente utilizados em terapia
intensiva pedi&#x000e1;trica, n&#x000e3;o est&#x000e1; inteiramente estabelecida. Estudos mostram que,
embora a utiliza&#x000e7;&#x000e3;o de cateteres arteriais seja fundamental para o cuidado do
paciente, &#x000e9; frequente a ocorr&#x000ea;ncia de eventos adversos que devem ser detectados
e tratados precocemente<sup>(</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>-</sup>
<xref rid="B14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup>.</p><p>Uma revis&#x000e3;o sistem&#x000e1;tica e meta-an&#x000e1;lise avaliou o efeito da heparina, o tempo de
perman&#x000ea;ncia e as complica&#x000e7;&#x000f5;es de cateteres arteriais e venosos, em crian&#x000e7;as e
adultos internados em terapia intensiva. Os achados evidenciaram que o uso
intermitente de solu&#x000e7;&#x000e3;o de heparina em concentra&#x000e7;&#x000f5;es de 10UI/mL foi ben&#x000e9;fico,
comparado ao uso isolado de solu&#x000e7;&#x000e3;o fisiol&#x000f3;gica 0,9%. Com essa concentra&#x000e7;&#x000e3;o de
solu&#x000e7;&#x000e3;o de heparina, os cateteres permaneceram perme&#x000e1;veis por um tempo maior em
compara&#x000e7;&#x000e3;o ao grupo que utilizou solu&#x000e7;&#x000e3;o fisiol&#x000f3;gica a 0,9%<sup>(</sup>
<xref rid="B15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup>.</p><p>Estudo recente incluiu revis&#x000e3;o de pesquisas cl&#x000ed;nicas que compararam diferentes
m&#x000e9;todos de manuten&#x000e7;&#x000e3;o da pat&#x000ea;ncia de cateteres venosos centrais em adultos. Os
autores conclu&#x000ed;ram que faltam evid&#x000ea;ncias que indiquem qual a melhor t&#x000e9;cnica a
ser empregada e afirmam que novos estudos s&#x000e3;o necess&#x000e1;rios<sup>(</sup>
<xref rid="B16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>,</sup>
<xref rid="B17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup>.</p><p>Frente &#x000e0; escassez de evid&#x000ea;ncias acerca da t&#x000e9;cnica mais indicada para manuten&#x000e7;&#x000e3;o
dos cateteres arteriais em crian&#x000e7;as, por meio do sistema de infus&#x000e3;o cont&#x000ed;nua de
solu&#x000e7;&#x000e3;o de heparina ou do sistema de infus&#x000e3;o intermitente de solu&#x000e7;&#x000e3;o de
heparina, s&#x000e3;o necess&#x000e1;rias estrat&#x000e9;gias seguras para cuidar dessa popula&#x000e7;&#x000e3;o de
maior risco. Assim, os objetivos deste estudo foram comparar dois sistemas de
manuten&#x000e7;&#x000e3;o de cateteres arteriais em p&#x000f3;s-operat&#x000f3;rio de cirurgia card&#x000ed;aca
pedi&#x000e1;trica, utilizando infus&#x000e3;o cont&#x000ed;nua ou intermitente de solu&#x000e7;&#x000e3;o de heparina,
bem como descrever as caracter&#x000ed;sticas cl&#x000ed;nicas e demogr&#x000e1;ficas das crian&#x000e7;as e
analisar os eventos adversos relacionados ao local de inser&#x000e7;&#x000e3;o do cateter e ao
volume de solu&#x000e7;&#x000e3;o de heparina infundido.</p></sec><sec><title>M&#x000e9;todo</title><p>Ensaio cl&#x000ed;nico randomizado e controlado que comparou dois sistemas de manuten&#x000e7;&#x000e3;o
e permeabiliza&#x000e7;&#x000e3;o de cateteres arteriais, em pacientes internados
consecutivamente em Unidade de Terapia Intensiva de um hospital cardiol&#x000f3;gico, de
outubro de 2007 a abril de 2009.</p><p>Realizou-se a randomiza&#x000e7;&#x000e3;o por meio de sorteio aleat&#x000f3;rio com envelopes fechados
que continham o grupo no qual o paciente seria inclu&#x000ed;do: Grupo Infus&#x000e3;o Cont&#x000ed;nua
(GIC) ou Grupo Infus&#x000e3;o Intermitente (GII). O estudo foi registrado no
<italic>Clinical Trials </italic>sob o n&#x000ba; NTC01097031. A equipe de
enfermagem da unidade preparou e administrou a solu&#x000e7;&#x000e3;o de heparina, conforme
rotina estabelecida: frascos-ampola de heparina endovenosa de 5.000UI/mL
dilu&#x000ed;dos com soro fisiol&#x000f3;gico 0,9% em frascos de 250mL, obtendo-se concentra&#x000e7;&#x000e3;o
final de 4UI/mL. Ap&#x000f3;s a dilui&#x000e7;&#x000e3;o final, as solu&#x000e7;&#x000f5;es tinham estabilidade de 24
horas, sendo trocadas assim que completassem esse per&#x000ed;odo.</p><p>Inclu&#x000ed;ram-se crian&#x000e7;as de ambos os sexos, com peso &#x0003c;15kg, submetidas &#x000e0; cirurgia
card&#x000ed;aca e internadas na Unidade de Terapia Intensiva Pedi&#x000e1;trica. Outras
cirurgias pedi&#x000e1;tricas e peso superior a 15kg foram considerados crit&#x000e9;rio de
exclus&#x000e3;o.</p><p>No GII, sortearam-se os pacientes para manuten&#x000e7;&#x000e3;o e permeabiliza&#x000e7;&#x000e3;o de cateteres
arteriais por infus&#x000e3;o intermitente de heparina. Utilizaram-se seringas
BD<sup>(r) </sup>de 5mL da solu&#x000e7;&#x000e3;o de heparina, com concentra&#x000e7;&#x000e3;o de 4UI/mL
(heparina/solu&#x000e7;&#x000e3;o fisiol&#x000f3;gica 0,9%). O sistema foi conectado ao paciente e ao
transdutor de press&#x000e3;o, atrav&#x000e9;s de extensores BD<sup>(r)</sup>; o transdutor de
press&#x000e3;o, por sua vez, foi ligado ao monitor, para se visualizar a curva cont&#x000ed;nua
da press&#x000e3;o arterial. Efetuaram-se infus&#x000f5;es somente quando necess&#x000e1;rio: nos casos
de refluxo de sangue, para calibragem do sistema e coleta de exames
laboratoriais.</p><p>No GIC, para manter e permeabilizar os cateteres arteriais por infus&#x000e3;o cont&#x000ed;nua,
utilizou-se bomba de infus&#x000e3;o de seringa Nikiso<sup>(r)</sup>, em velocidade de
0,5mL/hora, com solu&#x000e7;&#x000e3;o de heparina na concentra&#x000e7;&#x000e3;o de 4UI/mL (heparina/solu&#x000e7;&#x000e3;o
fisiol&#x000f3;gica 0,9%). O sistema foi conectado ao paciente e ao transdutor de
press&#x000e3;o, utilizando-se a bomba de infus&#x000e3;o, no total de 12mL de solu&#x000e7;&#x000e3;o de
heparina a cada 24 horas. Quando necess&#x000e1;rio, para a coleta de amostras
laboratoriais, foram dados <italic>flushes</italic> manuais de solu&#x000e7;&#x000e3;o de
heparina pela bomba de infus&#x000e3;o, com volume adequado para preencher as extens&#x000f5;es
e visualizar uma boa curva de press&#x000e3;o no monitor.</p><p>Para a coleta de dados, elaborou-se um instrumento no qual se registraram as
vari&#x000e1;veis cl&#x000ed;nicas e demogr&#x000e1;ficas para caracterizar a amostra, como idade, peso,
sexo, tipo de cardiopatia, cirurgia realizada, local da inser&#x000e7;&#x000e3;o do cateter,
volume da solu&#x000e7;&#x000e3;o de heparina e tempo de perman&#x000ea;ncia do cateter. Registraram-se
tamb&#x000e9;m eventos adversos como sangramento (presen&#x000e7;a de sangue no curativo ou no
s&#x000ed;tio de pun&#x000e7;&#x000e3;o da art&#x000e9;ria cateterizada); edema (ac&#x000fa;mulo anormal de l&#x000ed;quido no
espa&#x000e7;o intersticial local e observado pelo aumento da circunfer&#x000ea;ncia do membro
cateterizado em rela&#x000e7;&#x000e3;o ao membro oposto); hematoma (ac&#x000fa;mulo de sangue no tecido
subcut&#x000e2;neo no local de pun&#x000e7;&#x000e3;o e percebido &#x000e0; palpa&#x000e7;&#x000e3;o); m&#x000e1; perfus&#x000e3;o (est&#x000e1;gio
inicial de enchimento capilar inadequado); isquemia (etapa mais avan&#x000e7;ada de m&#x000e1;
perfus&#x000e3;o na qual se encontra tecido lesado); presen&#x000e7;a de co&#x000e1;gulo (aus&#x000ea;ncia de
refluxo sangu&#x000ed;neo no cateter e presen&#x000e7;a de trombo no interior deste ap&#x000f3;s sua
retirada)<sup>(</sup>
<xref rid="B18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>)</sup>.</p><p>A equipe de sa&#x000fa;de assistencial da unidade (m&#x000e9;dicos e enfermeiras) registraram
todas as vari&#x000e1;veis e um dos autores coletou os dados em quatro momentos
distintos: p&#x000f3;s-operat&#x000f3;rio imediato (POI) - chegada do paciente na Unidade de
Terapia Intensiva Pedi&#x000e1;trica at&#x000e9; completar 24 horas; primeiro dia de
p&#x000f3;s-operat&#x000f3;rio (1&#x000ba; PO) - ap&#x000f3;s 24 horas at&#x000e9; completar 48 horas de p&#x000f3;s-operat&#x000f3;rio;
segundo dia de p&#x000f3;s-operat&#x000f3;rio (2&#x000ba; PO) - ap&#x000f3;s 48 horas at&#x000e9; completar 72 horas de
p&#x000f3;s-operat&#x000f3;rio; terceiro dia de p&#x000f3;s-operat&#x000f3;rio (3&#x000ba; PO) - ap&#x000f3;s 72 horas de
p&#x000f3;s-operat&#x000f3;rio.</p><p>Desenvolveu-se o estudo de acordo com as Diretrizes e Normas Regulamentadoras de
Pesquisa Envolvendo Seres Humanos, sendo aprovado pelo Comit&#x000ea; de &#x000c9;tica e
Pesquisa do Instituto de Cardiologia do Rio Grande do Sul/Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria
de Cardiologia. Os pais/respons&#x000e1;veis foram convidados a participar e assinaram o
termo de consentimento livre e esclarecido.</p><p>Analisaram-se os dados pelo programa <italic>Statistical Package for the Social
Sciences</italic> (SPSS) 14.0. As vari&#x000e1;veis categ&#x000f3;ricas foram descritas por
frequ&#x000ea;ncias absolutas e relativas e as vari&#x000e1;veis cont&#x000ed;nuas, por m&#x000e9;dia e
desvio-padr&#x000e3;o ou mediana e intervalo interquart&#x000ed;lico (percentis 25 e 75),
conforme seguissem ou n&#x000e3;o distribui&#x000e7;&#x000e3;o normal. Aplicou-se o teste do
qui-quadrado de Pearson para comparar as vari&#x000e1;veis categ&#x000f3;ricas. J&#x000e1; o teste
<italic>t</italic> de Student foi aplicado para comparar as m&#x000e9;dias e as
medianas entre os grupos, conforme fossem respeitados ou n&#x000e3;o os pressupostos
param&#x000e9;tricos. Considerou-se um n&#x000ed;vel de signific&#x000e2;ncia de
<italic>p</italic>&#x0003c;0,05.</p><p>Para uma amostra de 70 sujeitos em cada grupo, encontrando-se desvio-padr&#x000e3;o de
15,5 e 14,8 para detectar uma diferen&#x000e7;a maior que oito dias de perman&#x000ea;ncia do
cateter, obteve-se poder de 87%.</p></sec><sec><title>Resultados</title><p>Selecionaram-se 141 crian&#x000e7;as em p&#x000f3;s-operat&#x000f3;rio de cirurgia card&#x000ed;aca pedi&#x000e1;trica,
sendo que uma n&#x000e3;o participou do estudo por n&#x000e3;o consentimento dos
pais/respons&#x000e1;veis (<xref ref-type="fig" rid="f03">Figura 1</xref>). Assim,
inclu&#x000ed;ram-se 140 pacientes, sendo 77 (55%) do sexo feminino. A mediana da idade
foi de 11 meses (0-22 meses) e a mediana do peso foi de 7,4kg (1,9-14,9kg).</p><p>
<fig id="f03" orientation="portrait" position="float"><label>Figura 1</label><caption><title> Fluxograma dos pacientes inclu&#x000ed;dos no estudo</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gf01-pt"/></fig>
</p><p>Quanto &#x000e0;s cardiopatias cong&#x000ea;nitas mais frequentes, diagnosticaram-se 26 (18,6%)
crian&#x000e7;as com tetralogia de <italic>Fallot</italic>, 14 (10%) com comunica&#x000e7;&#x000e3;o
interventricular (CIV) e 13 (9,3%) com atresia pulmonar com CIV para os dois
grupos analisados (<xref ref-type="table" rid="t03">Tabela 1</xref>).</p><p>
<table-wrap id="t03" orientation="portrait" position="float"><label>Tabela 1</label><caption><title> Caracter&#x000ed;sticas cl&#x000ed;nicas e demogr&#x000e1;ficas da popula&#x000e7;&#x000e3;o
(n=140)</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gt01-pt"/></table-wrap>
</p><p>Em rela&#x000e7;&#x000e3;o &#x000e0; ocorr&#x000ea;ncia de eventos adversos durante os tr&#x000ea;s primerios dias de
p&#x000f3;s-operat&#x000f3;rio de cirugia card&#x000ed;aca, registraram-se sangramento, edema, hematoma,
m&#x000e1; perfus&#x000e3;o, isquemia ou co&#x000e1;gulo em 63 (45%) crian&#x000e7;as, por&#x000e9;m sem diferen&#x000e7;a
significativa na compara&#x000e7;&#x000e3;o dos dois grupos (<italic>p</italic>=0,82) (<xref ref-type="table" rid="t04">Tabela 2</xref>).</p><p>
<table-wrap id="t04" orientation="portrait" position="float"><label>Tabela 2</label><caption><title> Eventos adversos relacionados ao local do cateter</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gt02-pt"/></table-wrap>
</p><p>Ainda considerando-se os dois grupos, em 28 (20,0%) casos houve quebra dos
cateteres e 27 (19,3%) crian&#x000e7;as tiveram alta da unidade de cuidados intensivos
at&#x000e9; o terceiro dia de p&#x000f3;s-operat&#x000f3;rio, motivos que culminaram na retirada dos
cateteres.</p><p>Ao se avaliar o local de inser&#x000e7;&#x000e3;o do cateter, em 56 (40,0%) crian&#x000e7;as, utilizou-se
a art&#x000e9;ria radial esquerda e, em 40 (28,6%), a art&#x000e9;ria radial direita, para os
dois grupos. A pun&#x000e7;&#x000e3;o por meio de transfixa&#x000e7;&#x000e3;o da art&#x000e9;ria foi utilizada em 138
(97,9%) crian&#x000e7;as e, em apenas uma (1,4%), para cada grupo, empregou-se
dissec&#x000e7;&#x000e3;o. O calibre do cateter mais utilizado foi 24G em 78 (55,7%)
crian&#x000e7;as.</p><p>Quanto ao tempo de perman&#x000ea;ncia dos cateteres, a mediana foi de 48 (24-70,5) horas
no GIC e de 48 (32-76,5) horas no GII. Como n&#x000e3;o se encontrou diferen&#x000e7;a maior que
oito dias de perman&#x000ea;ncia do cateter, n&#x000e3;o houve diferen&#x000e7;a entre os grupos
(<italic>p</italic>=1,0). Comparando-se a m&#x000e9;dia de volume utilizado no GII
(5,3&#x000b1;3,5mL/24 horas) com a do GIC (12,0&#x000b1;1,2mL/24 horas), os achados demonstraram
diferen&#x000e7;a significativa (<italic>p</italic>&#x0003c;0,0003) (<xref ref-type="fig" rid="f04">Figura 2</xref>).</p><p>
<fig id="f04" orientation="portrait" position="float"><label>Figura 2</label><caption><title> Volume de solu&#x000e7;&#x000e3;o de heparina utilizado a cada 24 horas nos dois
grupos</title></caption><graphic xlink:href="0103-0582-rpp-31-04-00516-gf02-pt"/></fig>
</p></sec><sec><title>Discuss&#x000e3;o</title><p>A monitoriza&#x000e7;&#x000e3;o da press&#x000e3;o arterial invasiva em crian&#x000e7;as tem sido amplamente
utilizada nos diversos servi&#x000e7;os de Pediatria. Atualmente, a cateteriza&#x000e7;&#x000e3;o
arterial &#x000e9; um procedimento indicado sempre que uma crian&#x000e7;a &#x000e9; submetida &#x000e0;
cirurgia card&#x000ed;aca. Por ser facilmente realiz&#x000e1;vel, em especial quando obtida por
pun&#x000e7;&#x000e3;o, permite a mensura&#x000e7;&#x000e3;o r&#x000e1;pida e precisa da press&#x000e3;o arterial e tamb&#x000e9;m
proporciona a coleta de amostras de sangue para exames laboratoriais<sup>(</sup>
<xref rid="B19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>)</sup>. O sucesso da medida invasiva da press&#x000e3;o arterial somente ocorre
quando o sistema de manuten&#x000e7;&#x000e3;o da permeabilidade do cateter n&#x000e3;o compromete a
seguran&#x000e7;a do paciente ou a precis&#x000e3;o e reprodutibilidade da medida.</p><p>O presente estudo comparou dois sistemas de manuten&#x000e7;&#x000e3;o e permeabiliza&#x000e7;&#x000e3;o de
cateteres arteriais em crian&#x000e7;as. O principal resultado demonstrado relacionou-se
ao volume de solu&#x000e7;&#x000e3;o de heparina utilizado em ambos os grupos. A m&#x000e9;dia de volume
utilizado no GII foi menor, quando comparado ao GIC.</p><p>O sistema de infus&#x000e3;o cont&#x000ed;nua &#x000e9; um m&#x000e9;todo confort&#x000e1;vel para o manipulador e
proporciona uma margem de seguran&#x000e7;a maior quanto ao volume infundido, em
compara&#x000e7;&#x000e3;o &#x000e0; t&#x000e9;cnica dos <italic>flushes</italic> r&#x000e1;pidos. O m&#x000e9;todo de infus&#x000e3;o
intermitente proporciona melhor observa&#x000e7;&#x000e3;o de todo o sistema quanto &#x000e0; presen&#x000e7;a
de ar e forma&#x000e7;&#x000e3;o de co&#x000e1;gulos pelo refluxo de sangue por press&#x000e3;o negativa,
atrav&#x000e9;s de uma seringa. Segundo estudo realizado em crian&#x000e7;as, os sistemas de
infus&#x000e3;o cont&#x000ed;nua diminu&#x000ed;ram a incid&#x000ea;ncia de emboliza&#x000e7;&#x000e3;o distal de 23% para zero
e ainda oferecem um melhor controle da quantidade de infus&#x000e3;o de solu&#x000e7;&#x000e3;o de
heparina<sup>(</sup>
<xref rid="B20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>.</p><p>A ocorr&#x000ea;ncia de um maior n&#x000fa;mero de complica&#x000e7;&#x000f5;es relaciona-se aos pacientes que
apresentam choque ou baixo d&#x000e9;bito<sup>(</sup>
<xref rid="B21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. &#x000c9; poss&#x000ed;vel que o grande n&#x000fa;mero de co&#x000e1;gulos notado no presente
estudo se associe &#x000e0; gravidade dos pacientes. Por serem cardiopatas, muitos
submetidos &#x000e0; cirurgia card&#x000ed;aca com circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea, apresentavam-se
frequentemente com insufici&#x000ea;ncia card&#x000ed;aca e quadro de baixo d&#x000e9;bito.</p><p>Habitualmente, crian&#x000e7;as com idade inferior a cinco anos apresentam maior &#x000ed;ndice
de complica&#x000e7;&#x000f5;es decorrentes da cateteriza&#x000e7;&#x000e3;o arterial, necessitando de mais
cuidados na monitoriza&#x000e7;&#x000e3;o invasiva devido &#x000e0;s r&#x000e1;pidas mudan&#x000e7;as press&#x000f3;ricas &#x000e0;s
quais est&#x000e3;o sujeitas no p&#x000f3;s-operat&#x000f3;rio, &#x000e0; instabilidade hemodin&#x000e2;mica e ao uso de
drogas vasoativas<sup>(</sup>
<xref rid="B11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>)</sup>. Neste estudo, n&#x000e3;o houve diferen&#x000e7;as significativas quanto &#x000e0; faixa
et&#x000e1;ria e ao peso das crian&#x000e7;as relacionados aos eventos adversos. Em outro
estudo, observacional retrospectivo, realizado com 1.473 crian&#x000e7;as de at&#x000e9; 20kg,
encontrou-se frequentemente oclus&#x000e3;o tempor&#x000e1;ria da art&#x000e9;ria canulada<sup>(</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup>. O local de pun&#x000e7;&#x000e3;o normalmente escolhido e com maior facilidade de
acesso foi radial e braquial, seguido do femoral, dados coincidentes com os
obtidos neste estudo.</p><p>Observou-se grande variabilidade no tempo de permeabilidade dos cateteres, com
mediana de 48 horas nos dois grupos estudados. Alguns trabalhos demonstraram
maior tempo m&#x000e9;dio de perman&#x000ea;ncia, com dura&#x000e7;&#x000e3;o m&#x000e9;dia de 72 horas para cateteres
arteriais<sup>(</sup>
<xref rid="B22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>. Outros observaram tempo de perman&#x000ea;ncia m&#x000e9;dio de 48
horas<sup>(</sup>
<xref rid="B22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>,</sup>
<xref rid="B23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>. Autores relatam que o uso do cateter arterial n&#x000e3;o deve ultrapassar
96 horas para diminuir os riscos de infec&#x000e7;&#x000e3;o<sup>(</sup>
<xref rid="B24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. Neste estudo, a grande variabilidade do tempo relacionada &#x000e0;
dura&#x000e7;&#x000e3;o do cateter arterial deve-se, provavelmente, &#x000e0; grande variabilidade de
tempo de interna&#x000e7;&#x000e3;o na Unidade de Terapia Intensiva. Muitos desses pacientes
apresentaram complica&#x000e7;&#x000f5;es p&#x000f3;s-operat&#x000f3;rias graves, necessitando de ventila&#x000e7;&#x000e3;o
mec&#x000e2;nica prolongada, di&#x000e1;lise peritonial e monitoriza&#x000e7;&#x000e3;o cont&#x000ed;nua para registro
da press&#x000e3;o arterial e obten&#x000e7;&#x000e3;o de coletas para amostras laboratoriais.</p><p>Comparando-se a m&#x000e9;dia de volume utilizado no GII (5,3&#x000b1;3,5mL/24 horas) com a m&#x000e9;dia
do GIC (12&#x000b1;1,2mL/24 horas), encontrou-se diferen&#x000e7;a significativa nos valores
di&#x000e1;rios de solu&#x000e7;&#x000e3;o de heparina infundida em cada grupo. Questiona-se se essa
diferen&#x000e7;a, estatisticamente importante, apresenta alguma repercuss&#x000e3;o na pr&#x000e1;tica
cl&#x000ed;nica. Por outro lado, o controle da volemia em pacientes pedi&#x000e1;tricos &#x000e9; um dos
cuidados primordiais para a boa evolu&#x000e7;&#x000e3;o hemodin&#x000e2;mica. Em crian&#x000e7;as muito
pequenas, o volume necess&#x000e1;rio para infundir drogas pode contribuir para uma
sobrecarga de volume<sup>(</sup>
<xref rid="B25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>,</sup>
<xref rid="B26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>.</p><p>A dose de heparina utilizada na literatura varia de 0,1-10UI/mL<sup>(</sup>
<xref rid="B27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup>. Neste estudo, utilizou-se concentra&#x000e7;&#x000e3;o de solu&#x000e7;&#x000e3;o de heparina a
4UI/mL em ambos os grupos. Os achados evidenciaram que 45% dos pacientes
apresentaram algum evento adverso. Destes, em 25% houve presen&#x000e7;a de co&#x000e1;gulo,
&#x000ed;ndice relativamente alto quando comparado com outros estudos. Alguns autores
demonstraram baixo &#x000ed;ndice de complica&#x000e7;&#x000f5;es, com apenas 3% de oclus&#x000e3;o do cateter
ao se usar a solu&#x000e7;&#x000e3;o de heparina de forma cont&#x000ed;nua, a 3mL/hora<sup>(</sup>
<xref rid="B26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>. Estudo realizado com pacientes adultos n&#x000e3;o relatou diferen&#x000e7;a de
permeabilidade dos cateteres ao comparar a manuten&#x000e7;&#x000e3;o com solu&#x000e7;&#x000e3;o fisiol&#x000f3;gica
normal a 0,9% e solu&#x000e7;&#x000e3;o fisiol&#x000f3;gica 0,9% com heparina, mas encontrou diferen&#x000e7;as
quanto &#x000e0; acur&#x000e1;cia dos valores da medida da press&#x000e3;o arterial, sendo os mais
precisos no grupo que utilizou heparina<sup>(</sup>
<xref rid="B28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>. Em crian&#x000e7;as entre um m&#x000ea;s e dois anos, cateterizadas na art&#x000e9;ria
radial e conectadas a um dispositivo com fluxo cont&#x000ed;nuo de infus&#x000e3;o a 3mL/hora
com solu&#x000e7;&#x000e3;o salina isot&#x000f4;nica heparinizada a 1UI heparina/mL, observou-se maior
n&#x000fa;mero de hemorragia e isquemia nas primeiras 72 horas<sup>(</sup>
<xref rid="B29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p><p>Sobrecarga volum&#x000e9;trica e insufici&#x000ea;ncia renal s&#x000e3;o fatores que contribuem de forma
significativa para aumentar a morbidade e a mortalidade p&#x000f3;s-operat&#x000f3;ria,
especialmente em rec&#x000e9;m-nascidos. A restri&#x000e7;&#x000e3;o h&#x000ed;drica &#x000e9; um recurso utilizado com
frequ&#x000ea;ncia, muitas vezes, at&#x000e9; o limite tolerado. Nessas circunst&#x000e2;ncias, qualquer
volume infundido pode ser significativo<sup>(</sup>
<xref rid="B29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p><p>Pode-se concluir que a escolha do sistema de infus&#x000e3;o cont&#x000ed;nua ou intermitente de
solu&#x000e7;&#x000e3;o de heparina, para a manuten&#x000e7;&#x000e3;o de cateter intra-arterial, independe das
caracter&#x000ed;sticas cl&#x000ed;nicas e demogr&#x000e1;ficas das crian&#x000e7;as, bem como da ocorr&#x000ea;ncia de
eventos adversos durante os tr&#x000ea;s primerios dias de p&#x000f3;s-operat&#x000f3;rio, como
evidenciado na amostra estudada. Entretanto, deve-se considerar a utiliza&#x000e7;&#x000e3;o do
sistema de infus&#x000e3;o intermitente em crian&#x000e7;as de baixo peso, devido a um menor
volume de solu&#x000e7;&#x000e3;o de heparina infundido.</p><p>Caracter&#x000ed;sticas como calibre dos cateteres, local de escolha e t&#x000e9;cnica empregada
para inser&#x000e7;&#x000e3;o dos mesmos n&#x000e3;o mostraram evid&#x000ea;ncias de maior tempo de perman&#x000ea;ncia
nos grupos estudados. A limita&#x000e7;&#x000e3;o do estudo reside no fato de n&#x000e3;o ter sido
verificado o n&#x000fa;mero de vezes em que o cateter foi manipulado pelos diferentes
profissionais envolvidos no cuidado com a crian&#x000e7;a. A maior manipula&#x000e7;&#x000e3;o dos
cateteres por meio da t&#x000e9;cnica dos <italic>flushes</italic> r&#x000e1;pidos pode ter
ocorrido no sistema de infus&#x000e3;o intermitente, o que influenciaria a efetividade
do uso desse sistema. Nesse sentido, s&#x000e3;o necess&#x000e1;rios mais estudos sobre o
tema.</p></sec></body></sub-article></article>